Triple
T2190687
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Xarelto |
E49852
|
entity |
| Predicate | hasAntidote |
P4524
|
FINISHED |
| Object |
andexanet alfa
Andexanet alfa is a recombinant modified human factor Xa protein used as a reversal agent to counteract the anticoagulant effects of factor Xa inhibitors such as rivaroxaban and apixaban.
|
E241384
|
NE FINISHED |
Provenance (6 batches)
| Stage | Batch ID | Job type | Status |
|---|---|---|---|
| creating | batch_69a88aaba3c48190b351cab9b26989ff |
elicitation | completed |
| NER | batch_69abbf9e99f08190892d34485c8f2f25 |
ner | completed |
| NED1 | batch_69ae5db0352c8190aa9c4c58460df3a4 |
ned_source_triple | completed |
| NED2 | batch_69ae5ec4a35c8190bffc7a183497e764 |
ned_description | completed |
| NEDg | batch_69ae5e60b45c819088bf18ae564f0d1a |
nedg | completed |
| PD | batch_69abbda32d1881909d1fd83a751fb21c |
pd | completed |
Created at: March 4, 2026, 7:46 p.m.